Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/22/1996CA2096003C Compositions of gastric acid-resistant microspheres containing buffered bile acids
10/22/1996CA2094974C Stable porfimer sodium compositions and methods for their manufacture
10/22/1996CA2066409C Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
10/22/1996CA2050822C Intermediate for making 3-oxo-4-aza-androst-1-ene 17-.beta.-ketones
10/22/1996CA2007655C Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
10/22/1996CA1338671C Light-induced killing of carcinoma cells
10/22/1996CA1338670C .beta.-lactam antibiotics
10/22/1996CA1338667C Anti-androgen compounds
10/22/1996CA1338662C Pharmaceutical dosage form for the medication of fish
10/22/1996CA1338660C Transdermal multipolymer drug delivery system
10/21/1996CA2174602A1 .alpha.-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/20/1996CA2172884A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
10/19/1996CA2174406A1 Antiarrhythmic and cardioprotective substituted indenoylguanidines
10/17/1996WO1996032492A1 Improved enzymatic synthesis of oligosaccharides
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032482A1 Bacteriocins
10/17/1996WO1996032395A1 Benzimidazole derivatives
10/17/1996WO1996032393A1 1,2,4-triazolo[4,3-b]pyridazine derivatives and their use
10/17/1996WO1996032392A1 ANELLATED β-CARBOLINES
10/17/1996WO1996032390A1 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO-[a,d]CYCLOHEPTEN-5,10-IMINES BY OPTICAL RESOLUTION
10/17/1996WO1996032389A1 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety
10/17/1996WO1996032387A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
10/17/1996WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/17/1996WO1996032385A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
10/17/1996WO1996032384A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/17/1996WO1996032383A1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
10/17/1996WO1996032382A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996WO1996032381A1 Carbazole derivative
10/17/1996WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
10/17/1996WO1996032379A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
10/17/1996WO1996032376A1 Novel borneol esters, process for their preparation and their pharmaceutical use
10/17/1996WO1996032375A1 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
10/17/1996WO1996032345A1 Metered dose inhaler for beclomethasone dipropionate
10/17/1996WO1996032160A1 Mask for treating cold
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032151A1 Metered dose inhaler for fluticasone propionate
10/17/1996WO1996032149A1 Pulmonary delivery of aerosolized medicaments
10/17/1996WO1996032138A1 Methods for treating respiratory disease
10/17/1996WO1996032137A2 Methods of inducing immune tolerance using immunotoxins
10/17/1996WO1996032136A1 Polysaccharide-bound nitric oxide-nucleophile adducts
10/17/1996WO1996032135A1 Pharmaceutical composition
10/17/1996WO1996032120A1 Anionic oxygen radicals containing therapeutic agents and their use in pain relief
10/17/1996WO1996032119A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996WO1996032118A1 Use of nitric oxide-releasing agents to treat impotency
10/17/1996WO1996032116A1 Compositions and methods for nucleic acid delivery to the lung
10/17/1996WO1996032115A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996WO1996032114A1 Combined hormonal contraception pharmaceutical preparation
10/17/1996WO1996032113A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods
10/17/1996WO1996032112A1 Dermatological preparation and method for treating actinic keratoses
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032110A1 Thrombin inhibitors
10/17/1996WO1996032109A2 Levobupivacaine and its use as an anaesthetic in pregnant women
10/17/1996WO1996032108A1 Treatment for ocular inflammation
10/17/1996WO1996032107A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
10/17/1996WO1996032105A1 Lactacystin analogs
10/17/1996WO1996032104A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
10/17/1996WO1996032103A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996032101A1 Cancerous metastasis inhibitor
10/17/1996WO1996032100A1 Compositions and methods for treating pain
10/17/1996WO1996032099A1 Metered dose inhaler for albuterol
10/17/1996WO1996032097A1 Solid compositions containing polyethyleneoxide and a non-amorphous active principle
10/17/1996WO1996032094A1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
10/17/1996WO1996032089A1 LOW pH SKIN-TREATMENT COMPOSITION
10/17/1996WO1996032081A1 Topical formulations and methods for treating hemorrhoidal pain
10/17/1996WO1996032003A2 Tetrahydroimidazopyridoindolediones and their use as medicaments
10/17/1996WO1996028185A3 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
10/17/1996WO1996027797A3 Zap 70 inhibitors and methods for treatment of zap 70 signal transduction disorders
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996WO1996026728A3 Use of moxonidine for the treatment of atherosclerosis
10/17/1996WO1996025933A3 Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks
10/17/1996WO1996025924A3 Use of fluorocarbon liquids for accelerating lung and other tissue growth
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
10/17/1996WO1996015809A3 Process for the preparation of a pharmacologically active chemical combination
10/17/1996WO1996008246A3 Inducers of gamma globin gene expression and screening assays therefor
10/17/1996DE19514694A1 Broad spectrum antiinfective agent
10/17/1996DE19514524A1 Anellierte beta-Carboline Fused-beta-carbolines
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996DE19513990A1 Benzimidazol-Derivate Benzimidazole derivatives
10/17/1996DE19512484A1 Kohlenhydratmodifizierte Cytostatika Carbohydrate-modified cytostatics
10/17/1996CA2467462A1 Metered dose inhaler for salmeterol
10/17/1996CA2391617A1 Pharmaceutical preparation and use
10/17/1996CA2368934A1 Metered dose inhaler for fluticasone propionate
10/17/1996CA2246629A1 Mask for treating cold
10/17/1996CA2226759A1 Tetracycline compounds used as cgmp specific pde inhibitors
10/17/1996CA2220827A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996CA2218179A1 Metered dose inhaler for beclomethasone dipropionate
10/17/1996CA2218033A1 Acetamide derivative, process for preparing the same, and a pharmaceutical composition containing the same
10/17/1996CA2217955A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
10/17/1996CA2217951A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996CA2217877A1 Preparation of chiral 5-aminocarbonyl-5h-dibenzo-¬a,d|cyclohepten-5,10-imines by optical resolution
10/17/1996CA2217863A1 Use of nitric oxide-releasing agents to treat impotency
10/17/1996CA2217817A1 Lactacystin analogs
10/17/1996CA2217719A1 Anellated .beta.-carbolines
10/17/1996CA2217707A1 Indole derivatives as cgmp-pde inhibitors
10/17/1996CA2217682A1 Thrombin inhibitors
10/17/1996CA2217599A1 Treatment for ocular inflammation
10/17/1996CA2217564A1 Pharmaceutical combination preparation for hormonal contraception
1 ... 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 ... 7860